The Discounted Cash Flow (DCF) valuation of Suven Life Sciences Ltd (SUVEN.NS) is (31.80) INR. With the latest stock price at 246.14 INR, the upside of Suven Life Sciences Ltd based on DCF is -112.9%.
Based on the latest price of 246.14 INR and our DCF valuation, Suven Life Sciences Ltd (SUVEN.NS) is a sell. selling SUVEN.NS stocks now will result in a potential gain of 112.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 10.7% - 16.0% | 13.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (52.35) - (22.70) | (31.80) |
| Upside | -121.3% - -109.2% | -112.9% |